CXCR4 and Miyoshi myopathy: 68Ga-Pentixafor, a labelled peptide with high affinity for CXCR4 and an excellent signal-to-noise ratio in CXCR4-expressing patients is a promising PET ligand [26,27,28], especially because it is possible to theranostically target MM using this reagent.